Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Accolade, Inc. - common stock (NQ:ACCD)

7.020 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 7, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	7.020
Bid (Size)	7.020 (20)
Ask (Size)	7.030 (7)
Prev. Close	7.020
Today's Range	7.020 - 7.020
52wk Range	6.855 - 7.030
Shares Outstanding	76,232,192
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday ↗

March 01, 2025

Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.

Via Benzinga

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

February 25, 2025

From Halper Sadeh LLC

Via Business Wire

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+1.7%	+1.7%

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders

February 19, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)

February 19, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday ↗

February 08, 2025

Via Benzinga

Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox ↗

January 31, 2025

Via Benzinga

Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock ↗

January 22, 2025

Via Benzinga

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies ↗

January 22, 2025

Via Benzinga

Accolade Q3 Earnings Assessment ↗

January 10, 2025

Via Benzinga

Earnings Scheduled For January 9, 2025 ↗

January 09, 2025

Via Benzinga

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia ↗

January 18, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)

January 13, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders

January 11, 2025

From Halper Sadeh LLC

Via GlobeNewswire

What's Going On With Accolade Stock Wednesday? ↗

January 08, 2025

Via Benzinga

Breaking Down Accolade: 8 Analysts Share Their Views ↗

December 17, 2024

Via Benzinga

ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD

January 08, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Why Is Accolade Stock Trading Over 100% On Tuesday? ↗

January 08, 2025

Via Benzinga

Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders

January 08, 2025

From Ademi LLP

Via Business Wire

Forecasting The Future: 6 Analyst Projections For Accolade ↗

October 09, 2024

Via Benzinga

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

January 08, 2025

From Halper Sadeh LLC

Via Business Wire

Transcarent To Acquire Accolade

January 08, 2025

From Transcarent

Via Business Wire

Transcarent To Acquire Accolade

January 08, 2025

From Accolade, Inc.

Via GlobeNewswire

Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms ↗

October 08, 2024

Via Benzinga

Accolade Announces Results for Fiscal Second Quarter 2025

October 08, 2024

From Accolade, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Accolade, Inc. - common stock publicly traded?

Yes, Accolade, Inc. - common stock is publicly traded.

What exchange does Accolade, Inc. - common stock trade on?

Accolade, Inc. - common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Accolade, Inc. - common stock?

The ticker symbol for Accolade, Inc. - common stock is ACCD on the Nasdaq Stock Market

What is the current price of Accolade, Inc. - common stock?

The current price of Accolade, Inc. - common stock is 7.020

When was Accolade, Inc. - common stock last traded?

The last trade of Accolade, Inc. - common stock was at 04/07/25 04:00 PM ET

What is the market capitalization of Accolade, Inc. - common stock?

The market capitalization of Accolade, Inc. - common stock is 535.15M

How many shares of Accolade, Inc. - common stock are outstanding?

Accolade, Inc. - common stock has 535M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.